Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 7/20 | 0.57 |
| ▸ | MMP3 | P08254 | 4/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | HPGD | P15428 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | HRH3 | Q9Y5N1 | 6/20 | 0.43 |
| ▸ | HRH2 | P25021 | 4/20 | 0.43 |
| ▸ | HRH1 | P35367 | 4/20 | 0.43 |
| ▸ | MMP1 | P03956 | 1/20 | 0.43 |
| ▸ | MMP9 | P14780 | 1/20 | 0.43 |
| ▸ | MMP13 | P45452 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21386579 | 1.00 | MMP2 (0.57) | MMP2MMP3ALDH1A1HPGDKDM4E | |
| SCHEMBL9146899 | 1.00 | MMP2 (0.57) | MMP2MMP3ALDH1A1HPGDKDM4E | |
| SCHEMBL18979622 | 0.95 | MMP2 (0.50) | MMP2MMP3ALDH1A1HPGDFFAR1 | |
| SCHEMBL13384911 | 0.90 | MMP2 (0.49) | MMP2MMP3ALDH1A1HPGDKDM4E | |
| SCHEMBL10705801 | 0.88 | FFAR1 (0.53) | MMP2MMP3ALDH1A1HPGDKDM4E | |
| SCHEMBL10705795 | 0.88 | FFAR1 (0.53) | MMP2MMP3ALDH1A1HPGDKDM4E | |
| SCHEMBL14601374 | 0.87 | ALDH1A1 (0.57) | MMP2MMP3ALDH1A1HPGDKDM4E | |
| SCHEMBL13384899 | 0.87 | MMP2 (0.55) | MMP2MMP3ALDH1A1HPGDKDM4E | |
| SCHEMBL13384909 | 0.87 | MMP2 (0.55) | MMP2MMP3ALDH1A1HPGDKDM4E | |
| SCHEMBL3274920 | 0.85 | MMP2 (0.59) | MMP2MMP3ALDH1A1HPGDKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1188 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4395350-A | Liquid crystal mixtures | HOFFMANN-LA ROCHE INC. (US) | 1983-07-26 | — | — | US | claimed |
| EP-0043904-A2 | Mixtures containing a dyestuff, dyestuffs and their use in liquid crystal mixtures | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1982-01-20 | — | — | EP | claimed |
| US-11739267-B2 | LC medium | MERCK PATENT GMBH (DE) | 2023-08-29 | — | — | US | disclosed |
| US-20230159825-A1 | LIQUID-CRYSTAL MEDIUM COMPRISING POLYMERIZABLE COMPOUNDS | MERCK PATENT GMBH (DE) | 2023-05-25 | — | — | US | disclosed |
| US-11299675-B2 | Polymerizable polar compound, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2022-04-12 | — | — | US | disclosed |
| US-11193066-B2 | Polymerizable compound and composition, liquid crystal composite, optical anisotropic body, liquid crystal display device and use thereof | JNC CORPORATION (JP) | 2021-12-07 | — | — | US | disclosed |
| US-20210214615-A1 | LIQUID CRYSTAL DISPLAY DEVICE AND DISPLAY UNIT | JNC CORPORATION (JP) | 2021-07-15 | — | — | US | disclosed |
| US-10975305-B2 | Piperidine derivative, liquid crystal composition, and liquid crystal display element | JNC CORPORATION (JP) | 2021-04-13 | — | — | US | disclosed |
| US-20210071080-A1 | COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2021-03-11 | — | — | US | disclosed |
| US-10865344-B2 | Low molecular weight polar compound for homogeneously aligning liquid crystal medium, and liquid crystal medium containing same | JNC CORPORATION (JP) | 2020-12-15 | — | — | US | disclosed |
| US-10787608-B2 | Liquid crystal display device including liquid crystal medium containing low molecular weight polar compound for homogeneously aligning liquid crystal medium | JNC CORPORATION (JP) | 2020-09-29 | — | — | US | disclosed |
| WO-1989009426-A1 | LIQUID CRYSTAL COLOUR DISPLAYS | THE SECRETARY OF STATE FOR DEFENCE IN HER BRITANNI (GB) | 1989-10-05 | — | — | WO | disclosed |
| US-4844836-A | LIQUID CRYSTALS | ADEKA ARGUS CHEMICAL CO., LTD. (JP) | 1989-07-04 | — | — | US | disclosed |
| US-4721367-A | AROMATIC ESTERS OF PYRAZINE | CANON KABUSHIKI KAISHA (JP) | 1988-01-26 | — | — | US | disclosed |
| US-4659499-A | Liquid crystal materials | CRYSTALOID ELECTRONICS COMPANY (US) | 1987-04-21 | — | — | US | disclosed |
| US-4602850-A | Light valve display having integrated driving circuits and shield electrode | VIDIUM, INC. (US) | 1986-07-29 | — | — | US | disclosed |
| EP-0175591-A2 | Lactic acid derivative, liquid crystal composition containing same and liquid crystal device | CANON KABUSHIKI KAISHA (JP) | 1986-03-26 | — | — | EP | disclosed |
| EP-0065869-B1 | LIQUID CRYSTALLINE MATERIALS INCORPORATING DICHROIC DYE AND OPTICAL DISPLAYS UTILIZING SAME | Crystaloid Electronics Company (US) | 1984-07-25 | — | — | EP | disclosed |
| US-4395350-A | Liquid crystal mixtures | HOFFMANN-LA ROCHE INC. (US) | 1983-07-26 | — | — | US | disclosed |
| EP-0043904-A2 | Mixtures containing a dyestuff, dyestuffs and their use in liquid crystal mixtures | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1982-01-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11193066-B2 | Polymerizable compound and composition, liquid crystal composite, optical anisotropic body, liquid crystal display device and use thereof | OCIAD2, PYM1, C1S | MMP2 3099/4885MMP3 3857/4885ALDH1A1 4091/4885 |
| US-10787608-B2 | Liquid crystal display device including liquid crystal medium containing low molecular weight polar compound for homogeneously aligning liquid crystal medium | ACP1, MAPK1, PLD1 | MMP2 722/4885MMP3 817/4885ALDH1A1 4001/4885 |
| US-10865344-B2 | Low molecular weight polar compound for homogeneously aligning liquid crystal medium, and liquid crystal medium containing same | ACP1, MFAP1, PHOSPHO1 | MMP2 731/4885MMP3 538/4885ALDH1A1 4483/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.